1st Quarter - Report

COVIDIEN LP for COVIDIEN LP

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$470,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2011 $470,000 Replaced
1st Quarter - Amendment Jul 21, 2011 $510,000 Replaced
1st Quarter - Amendment Nov 25, 2011 $610,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S.23/H.R.1249 - America Invents Acts-regarding all provisions

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1249 (112th), S. 23 (112th)

Pharmacy PHA

Issues involving controlled substance and pain and addiction drungs generally. Issues related to acetaminophen.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

International tax on foreign direct investment generally.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
TIMOTHY MCBRIDE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

General issues related to FDA device approval process; Issues related to Patient Protection and Affordable Care Act Implementation (Accountable Care Organization Medical Device Tax); Medical Device Tax Repeal (S.17, S.262, H.R. 436, H.R. 488, H.R. 734); HEU/LEU related issues for Nuclear Medicine: S.99 - American Medical Isotopes Production Act- issues regarding all provisions.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 262 (112th), H.R. 436 (112th), S. 99 (112th), H.R. 488 (112th), S. 17 (112th), H.R. 734 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.